雜志介紹

Cell Reports Medicine雜志介紹

《Cell Reports Medicine》是一本以English為主的開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)細(xì)胞醫(yī)學(xué)報(bào)道，本刊主要出版、報(bào)道醫(yī)學(xué)-MEDICINE, RESEARCH & EXPERIMENTAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為11.7，最新CiteScore 指數(shù)為15。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Current understanding of the intratumoral microbiome in various tumors

  Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

• Inherited mutations in Chinese patients with upper tract urothelial carcinoma

  Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

• Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

  Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

• Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

  Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

英文介紹

Cell Reports Medicine雜志英文介紹

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.